Earum Pharmaceuticals
Earum Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Earum Pharmaceuticals
Start SIPEarum Pharmaceuticals Investment Rating
-
Master Rating:
-
Earum Pharmaceuticals has an operating revenue of Rs. 17.30 Cr. on a trailing 12-month basis. An annual revenue de-growth of -43% needs improvement, Pre-tax margin of 15% is great, ROE of 13% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 139 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 1 | 7 | 4 | 5 |
| Operating Expenses Qtr Cr | 1 | 7 | 5 | 10 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | -5 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 1 |
| Net Profit Qtr Cr | 1 | 0 | 0 | -1 |
Earum Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 2.26
- 50 Day
- 2.37
- 100 Day
- 2.57
- 200 Day
- 3.4
- 20 Day
- 2.27
- 50 Day
- 2.39
- 100 Day
- 2.5
- 200 Day
- 2.82
Earum Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 2.25 |
| Second Resistance | 2.38 |
| Third Resistance | 2.53 |
| RSI | 34.41 |
| MFI | 30.81 |
| MACD Single Line | -0.06 |
| MACD | -0.07 |
| Support | |
|---|---|
| First Resistance | 1.97 |
| Second Resistance | 1.82 |
| Third Resistance | 1.69 |
Earum Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 195,787 | 13,237,159 | 67.61 |
| Week | 264,122 | 19,249,226 | 72.88 |
| 1 Month | 206,356 | 15,844,043 | 76.78 |
| 6 Month | 446,864 | 30,954,260 | 69.27 |
Earum Pharmaceuticals Result Highlights
Earum Pharmaceuticals Synopsis
BSE-Medical-Whlsle Drg/Suppl
Earum Pharmaceutical is involved in the business activities of Manufacture of other chemical products. Company’s Total Operating Revenue is Rs. 21.04 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2022. Earum Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 26/07/2012 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2012PLC071299 and registration number is 071299.| Market Cap | 13 |
| Sales | 17 |
| Shares in Float | 6.17 |
| No of funds | |
| Yield |
| Book Value | 0.79 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | 16 |
| Alpha | -0.31 |
| Beta | 0.44 |
Earum Pharmaceuticals
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 37.57% | |||
| Individual Investors | 95.05% | 95.48% | 56.92% | |
| Others | 4.95% | 4.52% | 5.51% |
Earum Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Bhumishth Patel | Managing Director |
| Ms. Payal Patel | WholeTime Director & CFO |
| Mr. Dahyabhai Patel | Non Executive Director |
| Mr. Parimal Patwa | Independent Director |
| Mr. Harsh Kothari | Independent Director |
| Mr. Bhavesh Sonesara | Independent Director |
Earum Pharmaceuticals Forecast
Price Estimates
Earum Pharmaceuticals FAQs
What is Share Price of Earum Pharmaceuticals ?
Earum Pharmaceuticals share price is ₹2 As on 30 March, 2023 | 10:21
What is the Market Cap of Earum Pharmaceuticals ?
The Market Cap of Earum Pharmaceuticals is ₹13.4 Cr As on 30 March, 2023 | 10:21
What is the P/E ratio of Earum Pharmaceuticals ?
The P/E ratio of Earum Pharmaceuticals is 12.7 As on 30 March, 2023 | 10:21
What is the PB ratio of Earum Pharmaceuticals ?
The PB ratio of Earum Pharmaceuticals is 0.8 As on 30 March, 2023 | 10:21